Last reviewed · How we verify

On-Q Pain Ball

Pacira Pharmaceuticals, Inc · FDA-approved active Small molecule

On-Q Pain Ball is a elastomeric infusion pump that delivers local anesthetic (bupivacaine) continuously to surgical sites for post-operative pain management.

On-Q Pain Ball is a elastomeric infusion pump that delivers local anesthetic (bupivacaine) continuously to surgical sites for post-operative pain management. Used for Post-operative pain management following surgical procedures, Infiltration anesthesia for wound pain control.

At a glance

Generic nameOn-Q Pain Ball
Also known asbupivacaine
SponsorPacira Pharmaceuticals, Inc
Drug classLocal anesthetic infusion pump
TargetVoltage-gated sodium channels (via bupivacaine)
ModalitySmall molecule
Therapeutic areaPain Management / Anesthesia
PhaseFDA-approved

Mechanism of action

The device is a non-electronic, portable pump pre-filled with bupivacaine that provides continuous infiltration of local anesthetic around the surgical wound for up to 72 hours post-operatively. It works by diffusion-driven delivery, gradually releasing the anesthetic to block pain signals at the surgical site, reducing the need for systemic opioids and other analgesics during the critical early post-operative period.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: